Grandfield & Dodd LLC Purchases 2,101 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Grandfield & Dodd LLC raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.7% in the third quarter, HoldingsChannel reports. The firm owned 322,889 shares of the company’s stock after acquiring an additional 2,101 shares during the period. GE HealthCare Technologies comprises about 1.8% of Grandfield & Dodd LLC’s investment portfolio, making the stock its 21st largest holding. Grandfield & Dodd LLC’s holdings in GE HealthCare Technologies were worth $30,303,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the company. First Horizon Advisors Inc. increased its position in GE HealthCare Technologies by 8.4% during the 3rd quarter. First Horizon Advisors Inc. now owns 5,950 shares of the company’s stock valued at $558,000 after purchasing an additional 459 shares during the period. Advisors Asset Management Inc. increased its holdings in GE HealthCare Technologies by 28.2% during the third quarter. Advisors Asset Management Inc. now owns 97,430 shares of the company’s stock valued at $9,144,000 after buying an additional 21,413 shares during the period. Jennison Associates LLC increased its holdings in GE HealthCare Technologies by 56.4% during the third quarter. Jennison Associates LLC now owns 761,618 shares of the company’s stock valued at $71,478,000 after buying an additional 274,657 shares during the period. Prospera Private Wealth LLC purchased a new stake in GE HealthCare Technologies during the third quarter worth $69,000. Finally, Avior Wealth Management LLC lifted its holdings in GE HealthCare Technologies by 13.9% during the third quarter. Avior Wealth Management LLC now owns 3,871 shares of the company’s stock worth $363,000 after buying an additional 472 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Stock Down 0.2 %

GE HealthCare Technologies stock opened at $82.52 on Wednesday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. GE HealthCare Technologies Inc. has a fifty-two week low of $66.39 and a fifty-two week high of $94.55. The company has a market cap of $37.70 billion, a PE ratio of 22.67, a PEG ratio of 2.93 and a beta of 1.24. The business’s 50-day simple moving average is $88.59 and its two-hundred day simple moving average is $83.57.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company had revenue of $4.86 billion for the quarter, compared to the consensus estimate of $4.87 billion. During the same quarter in the prior year, the company earned $0.99 EPS. GE HealthCare Technologies’s quarterly revenue was up .9% on a year-over-year basis. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $0.03 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. GE HealthCare Technologies’s payout ratio is currently 3.30%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Stifel Nicolaus boosted their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a report on Monday, September 30th. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their price target for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. Finally, JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 target price for the company. One analyst has rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $94.36.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.